Study guide

11.1 Prescription Transfers Between Pharmacies

Minnesota MPJE Pharmacy Jurisprudence

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 About the Minnesota MPJE 1.2 NABP Competency Areas & Weights 1.3 How to Use This Guide & Study Strategy

2 Federal Controlled Substances Foundations

2.1 CSA Schedules I–V & MN Alignment 2.2 DEA Registration, Forms 222/106/41 & Security 2.3 Federal CS Prescription Rules (CII–CV) 2.4 Inventories, Recordkeeping & Theft/Loss

3 Federal Drug Regulation, Privacy & Supply Chain

3.1 FD&C Act, Legend vs OTC, Misbranding & Adulteration 3.2 OBRA '90, Medicaid DUR & Federal Counseling Floor 3.3 HIPAA Privacy for Pharmacy 3.4 DSCSA & Drug Supply Chain Integrity

4 MN Board, Licensure & Eligibility

4.1 Minnesota Board of Pharmacy Authority & Sources of Law 4.2 Pharmacist Licensure by Exam & Score Transfer 4.3 License Transfer (Reciprocity) & Background Checks 4.4 Interns, Preceptors & 1,600-Hour Experience

5 Renewal, CE, PIC & Discipline

5.1 License Renewal & 30-Hour Biennial CE 5.2 Pharmacist-in-Charge Duties 5.3 Discipline & Unprofessional Conduct 5.4 HPSP, Impaired Practitioners & Mandatory Reporting

6 Technicians, Interns & Supervision

6.1 Technician Registration, Training & CE 6.2 Supervision Ratios (Statute 151.102 & Rule 6800.3850) 6.3 Intern Scope, Delegation & Certification of Accuracy

7 Prescription Authority & Validity

7.1 Who May Prescribe in Minnesota 7.2 Prescription Content & Validity Requirements 7.3 Controlled Substance Prescribing (Chapter 152 + Federal) 7.4 Refills, Partial Fills & Quantity Limits

8 Advanced MN Pharmacist Practice

8.1 Collaborative Practice Agreements & Medication Therapy Management 8.2 Pharmacist Prescriptive Authority (Minn. Stat. 151.37) 8.3 Immunizations & Vaccine Administration 8.4 Drug Administration & Therapy Management

9 Counseling, DUR & Patient Safety

9.1 Patient Counseling Requirements (Rule 6800.0910) 9.2 Prospective Drug Utilization Review 9.3 Returning & Reusing Drugs (Rule 6800.2700)

10 MN PMP & Opioid Public-Health Laws

10.1 Minnesota PMP Overview, Reporting & Pharmacist Use 10.2 Naloxone Access, Steve’s Law & Opioid Antagonists 10.3 Legitimate Medical Purpose & Red Flags

11 Dispensing: Transfers, Labels & Substitution

11.1 Prescription Transfers Between Pharmacies 11.2 Labeling & Packaging of Dispensed Drugs 11.3 Generic Substitution & Product Selection 11.4 Emergency Dispensing, OTC/BTC & Pseudoephedrine

12 Pharmacy Operations & Facilities

12.1 Pharmacy Permits, Classifications & Inspections 12.2 Security, Delivery & Work Conditions 12.3 Operational Recordkeeping & Inventories 12.4 Central Fill, Centralized Processing & Automation

13 Compounding & Hazardous Drugs

13.1 Sterile, Nonsterile & Hazardous Compounding 13.2 Minnesota Compounding Rules & Beyond-Use Dates

14 Test-Day Strategy & Final Review

14.1 When Minnesota Law Is Stricter Than Federal Law 14.2 Test-Day Strategy & Common Traps

11.1 Prescription Transfers Between Pharmacies

Key Takeaways Explain This Topic AI

Minnesota Rule 6800.3120 allows refill transfers only when a licensed pharmacist or registered intern communicates directly with another licensed pharmacist or registered intern

A prescription label, copy, or telephone report alone has no legal status as a valid order—the receiving pharmacy must obtain a proper transfer or prescriber authorization

The written rule states Schedule II orders may not be transferred; Schedules III–V follow DEA transfer limits, with extra DEA-number documentation on both ends

Both pharmacies must void/mark the record, exchange required elements (including remaining refills), retain records at least two years from last fill, and notify the patient that the original is invalidated

Common electronic files and board-approved central-service real-time databases are not treated as ordinary transfers; nondispensed profiled orders may move under subpart 8a when QA and profile conditions are met

Last updated: July 2026

11.1 Prescription Transfers Between Pharmacies

Quick Answer: Under Minnesota Rule 6800.3120 , a pharmacy may transfer prescription drug order information for refilling when a licensed pharmacist or registered intern communicates directly with another licensed pharmacist or registered intern . The transferring side voids the original and records the receiving pharmacy; the receiving side marks the order “transfer”/“copy” and captures all required elements plus refill history. Schedule II orders are not transferable under the written rule ; Schedules III–V follow DEA transfer limits with DEA numbers documented. Both pharmacies keep records at least two years from last fill, and the patient must be told the original is invalidated .

Transfers sit in NABP Area 3 (Dispensing Requirements) —competency 3.2. Minnesota’s rule is highly testable because it names who may transfer, what must be written, and when a transfer is not a transfer at all.

Labels, Copies, and Reports Are Not Prescriptions (Subp. 1)

A prescription label , a written copy , or a telephone report from another pharmacy may be used for informational purposes only and has no legal status as a valid prescription drug order. If you receive only a label or casual copy, you must either:

  • Contact the prescribing practitioner for authorization to dispense, or
  • Complete a proper transfer under subparts 2–6

Exam trap: filling from a bottle label “because the patient is waiting” without a transfer or new order.

Who May Transfer and for What Purpose (Subp. 2)

  • Purpose Rule path
  • Refill of an existing order Direct pharmacist/intern ↔ pharmacist/intern communication
  • Initial fill of an order never dispensed Only under subpart 8a (nondispensed electronic orders)
  • Schedule II Written rule: may not be transferred (see modern federal/Board nuance below)
  • Schedules III–V Transferable within DEA limitations

Technicians and clerks do not perform the transfer conversation. Interns may transfer when registered and acting within the rule’s pharmacist/intern pathway —not as unsupervised free agents.

Duties of the Transferring Pharmacist or Intern (Subp. 3)

The transferring pharmacist or intern shall:

Write “VOID” across the face of the current prescription (or, if electronic, void all remaining refills in the electronic record)

Record on the reverse side (or electronic record) the name, address, and telephone number of the receiving pharmacy and the name of the receiving pharmacist or intern

Record the date of the transfer

Electronic cancellation is acceptable only when the quality-assurance check required by Rule 6800.3950, subpart 4 , has been completed on the order being transferred.

Extra for Schedules III–V

For CIII–V, also record the DEA registration number of the receiving pharmacy and the names of both the receiving and transferring pharmacists or interns.

Duties of the Receiving Pharmacist or Intern (Subp. 4)

Mark the face of the transferred prescription with “transfer,” “copy,” or a word of similar import, and obtain all information required by law to be on a prescription , plus:

  • Required add-on Why it matters
  • Date of issuance and of original filling Starts legal clocks
  • Original number of refills authorized Caps total supply
  • Number of valid refills remaining Prevents overfill
  • Date of last refill from the original Continuity
  • Original prescription number Audit trail
  • Transferring pharmacy name, address, telephone , and transferring pharmacist/intern name Accountability
  • For CIII–V: transferring pharmacy DEA number Federal/state CS trail
  • Retention, Patient Notice, and Shared Systems

Subp. 5: Both transferring and receiving pharmacies keep the (original or transferred) order at least two years from the date of last filling .

Subp. 6: The pharmacist conferring with the patient at the transfer request must inform the patient that the original prescription has been invalidated at the pharmacy from which it was obtained.

Subp. 7: A computerized system must still satisfy subparts 2–6. Pharmacies accessing a common electronic file/database used for required dispensing information are not required to “transfer” among participants in that same common file—but the common file must hold complete records , and a hard-copy record of each order transferred or accessed for refill must be generated and maintained at the pharmacy refilling or receiving the order.

Subp. 8: If transfer is initiated from a container previously filled at another pharmacy, the receiving pharmacist must notify the transferring pharmacist and exchange all required information.

Subp. 11: Real-time, online sharing under a board-approved central service operation is not treated as a prescription copy under this part.

Nondispensed (Never-Filled) Orders — Subp. 8a

Orders entered into a computer but never dispensed may be transferred if:

  • All order information is in the transferring pharmacy’s system
  • The profile clearly shows the order was not filled there

Unique identifiers exist for the data-entry person, the pharmacist who certified entry, and the pharmacist who performed 6800.3950 subp. 4 QA—or, if QA has not occurred, information must come from the original written order

  • The original is retained per Minn. Stat. §151.211
  • All other requirements of the part are met
  • Schedule II: Written Rule vs. Federal Electronic Transfer Reality

Subparts 2 and 10 of Rule 6800.3120 state that nothing in the part authorizes transfer of a Schedule II order and that CII orders must conform to the federal CSA/DEA rules. Federally, after the 2023 revision of 21 CFR 1306.08 , a pharmacy may transfer an electronic Schedule II–V prescription for initial filling to another retail pharmacy on patient request , subject to federal conditions (one-time electronic transfer for initial fill; written/oral CS scripts are not authorized for that initial-fill pathway).

The Minnesota Board of Pharmacy has published guidance that, while the written rule still prohibits CII transfer, the Board does not intend to enforce that CII restriction when the pharmacist fully complies with federal 1306.08 and with all other 6800.3120 requirements. On the MPJE, know both layers: the codified “CII not transferable” statement and the modern electronic initial-fill federal pathway with Board enforcement discretion. Do not invent transfers of paper or oral CII prescriptions for initial fill.

Unprofessional Conduct (Subp. 9)

It is unprofessional to reveal the nature of services rendered without patient consent or court order—except that a pharmacist/intern may provide informational copies to another pharmacist/intern currently serving the patient (as this part allows), to the patient, or drug-therapy information to other treating clinicians. It is also unprofessional for a pharmacist to refuse a legal transfer request from another pharmacist acting on the patient’s behalf.

Study Checklist

Who may transfer: pharmacist or registered intern only , direct communication.

List transferring and receiving documentation steps cold.

Separate common-file and central-service exceptions from ordinary transfers.

Apply CIII–V DEA limits and CII written-rule / electronic-federal nuance.

Always void , notify the patient , and keep two-year files.

Master transfers as a dual-pharmacy documentation event, not a favor between clerks.